Lv1
10 积分 2026-04-01 加入
In vivo CAR-T cell engineering in refractory SLE
1小时前
已完结
Heterogeneous responses of IM19 anti-CD19 CAR T-cell therapy in refractory systemic lupus erythematosus: an open-label pilot study and a mini-review
1小时前
已完结
Allogeneic CD19-targeted CAR-T therapy in refractory systemic lupus erythematosus achieved durable remission
3小时前
已完结
BCMA-CD19 compound CAR T cells for systemic lupus erythematosus: a phase 1 open-label clinical trial
3小时前
已完结
皖公网安备34019202002308
